NeuroPace Inc. (NPCE)
11.63
0.49 (4.35%)
At close: Apr 28, 2025, 3:59 PM
11.62
-0.09%
After-hours: Apr 28, 2025, 04:05 PM EDT
Company Description
NeuroPace, Inc. operates as a medical device company in the United States.
It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source.
The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely.
It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures.
The company was incorporated in 1997 and is headquartered in Mountain View, California.
NeuroPace Inc.
| Country | United States |
| IPO Date | Apr 22, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 184 |
| CEO | Joel D. Becker |
Advertisement
Contact Details
Address: 455 North Bernardo Avenue Mountain View, California United States | |
| Website | https://www.neuropace.com |
Stock Details
| Ticker Symbol | NPCE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001528287 |
| CUSIP Number | 641288105 |
| ISIN Number | US6412881053 |
| Employer ID | 22-3550230 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Joel D. Becker | Chief Executive Officer, President & Director |
| Rebecca L. Kuhn | Chief Financial Officer and Vice President of Finance & Administration |
| Amy Treadwell | Vice President of Human Resources |
| Dr. Martha J. Morrell M.D. | Chief Medical Officer |
| Dylan St. John | Chief of Operations & Development |
| Katie Keller | Vice President of Marketing |
| Kelley Nicholas | Vice President of Sales |
| Leah Akin | General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2025 | 4 | Filing |
| Apr 23, 2025 | 4 | Filing |
| Apr 22, 2025 | ARS | Filing |
| Apr 22, 2025 | DEFA14A | Filing |
| Apr 22, 2025 | DEF 14A | Filing |
| Apr 14, 2025 | 8-K | Current Report |
| Apr 02, 2025 | 8-K | Current Report |
| Mar 24, 2025 | 4 | Filing |
| Mar 20, 2025 | 4 | Filing |
| Mar 20, 2025 | 4 | Filing |